Stereotactic radiotherapy for oligometastatic disease​

 

Friday, 21 May 2027

Course directors:

  • Marianne Guren 
  • Peter van Rossum 
  • Jonas Willman

Course aim: 

Best practice of SBRT for oligometastatic disease

Learning objectives: 

Learn how to select patients for treatment of oligometastatic disease, and how to choose a safe treatment regimen with good efficacy

Target audience

Radiation oncologists, medical physicists, dosimetrists

Scientific programme

The scientific programme is available here.

Pre-course Webinar

More information to be published soon.

Accreditation

Application for CME recognition will be submitted to the European Accreditation Council for Continuing Medical Education (EACCME), an institution of the European Union of Medical Specialists (UEMS). EACCME credits are recognised by the American Medical Association towards the Physician’s Recognition Award (PRA). Information on the status of the applications can be obtained from the ESTRO office.